Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Iacobelli · SciRah

Researcher profile · Semantic Scholar

S. Iacobelli

Share profile

S. Iacobelli — researcher profile on SciRah

h-index: 50
Works: 297
Citations: 11K

Most-cited papers

Antibody-Drug Conjugates: The New Frontier of Chemotherapy
S. Ponziani, Giulia Di Vittorio, G. Pitari, A. Cimini +8 more
2020International Journal of Molecular Sciences151 citations Open access
Semantic Scholar
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis.
S. Giacchetti, P. Dugué, P. F. Innominato, G. Bjarnason +10 more
2012Annals of Oncology149 citations Open access
Semantic Scholar
Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed
D. Croci, A. Cumashi, N. Ushakova, M. E. Preobrazhenskaya +16 more
2011PLoS ONE144 citations Open access
Semantic Scholar
Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer
P. Innominato, S. Giacchetti, G. Bjarnason, C. Focan +8 more
2012International Journal of Cancer135 citations Open access
Semantic Scholar
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
E. Capone, S. Iacobelli, G. Sala
2021Journal of Translational Medicine127 citations Open access
Semantic Scholar
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
A. Marchetti, M. Milella, L. Felicioni, F. Cappuzzo +14 more
2009Neoplasia105 citations Open access
Semantic Scholar
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy
M. Di Nisio, N. Ferrante, M. De Tursi, S. Iacobelli +4 more
2010Thrombosis and Haemostasis96 citations
Semantic Scholar
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
Enza Piccolo, N. Tinari, D. Semeraro, S. Traini +13 more
2012Journal of molecular medicine88 citations
Semantic Scholar
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.
M. Zilli, A. Grassadonia, N. Tinari, A. DiGiacobbe +4 more
2009Biochimica et Biophysica Acta85 citations
Semantic Scholar
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
M. Momeny, J. Saunus, Flavia Marturana, A. McCart Reed +10 more
2015OncoTarget73 citations Open access
Semantic Scholar
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer
G. Corda, G. Sala, R. Lattanzio, M. Iezzi +21 more
2016Journal of Pathology71 citations Open access
Semantic Scholar
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention
Pavlos Stampolidis, Axel Ullrich, S. Iacobelli
2013Oncogene67 citations
Semantic Scholar
The Use of the Eurosystem's Monetary Policy Instruments and Operational Framework since 2009
F. Eser, Marta Carmona Amaro, S. Iacobelli, Marc Rubens
2012Social Science Research Network67 citations Open access
Semantic Scholar
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
M. Belfiglio, C. Fanizza, N. Tinari, C. Ficorella +3 more
2011Journal of Cancer Research and Clinical Oncology65 citations Open access
Semantic Scholar
Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin–5-Fluorouracil–Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)
P. Innominato, S. Giacchetti, T. Moreau, R. Smaaland +9 more
2011Chronobiology International58 citations Open access
Semantic Scholar
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice
T. Pannellini, M. Iezzi, M. Liberatore, F. Sabatini +7 more
2010Cancer Prevention Research56 citations Open access
Semantic Scholar
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer
P. Innominato, S. Giacchetti, T. Moreau, G. Bjarnason +11 more
2013Cancer47 citations Open access
Semantic Scholar
Arterial thrombosis in ambulatory cancer patients treated with chemotherapy.
M. Di Nisio, N. Ferrante, B. Feragalli, M. De Tursi +3 more
2011Thrombosis Research46 citations
Semantic Scholar
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Lucía Gandullo-Sánchez, E. Capone, A. Ocaña, S. Iacobelli +2 more
2020EMBO Molecular Medicine43 citations Open access
Semantic Scholar
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.
F. Giansanti, E. Capone, S. Ponziani, Enza Piccolo +12 more
2019Journal of Controlled Release42 citations Open access
Semantic Scholar
Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum
A. Okyar, Enza Piccolo, Constance Ahowesso, E. Filipski +6 more
2011PLoS ONE41 citations Open access
Semantic Scholar
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1‐T2, N0 breast cancer patients undergoing adjuvant chemotherapy
R. Lattanzio, M. Marchisio, R. La Sorda, N. Tinari +11 more
2013International Journal of Cancer40 citations Open access
Semantic Scholar
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
E. Capone, A. Lamolinara, F. Pastorino, R. Gentile +18 more
2020Cancers36 citations Open access
Semantic Scholar
LIVER CIRCADIAN CLOCK, A PHARMACOLOGIC TARGET OF CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB
I. Iurisci, E. Filipski, Hatem Sallam, F. Harper +5 more
2009Chronobiology International36 citations
Semantic Scholar
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
P. Prasetyanti, E. Capone, D. Barcaroli, D. D'Agostino +9 more
2015OncoTarget35 citations Open access
Semantic Scholar
EV20‐mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
E. Capone, A. Lamolinara, D. D'Agostino, C. Rossi +4 more
2018Journal of Controlled Release34 citations Open access
Semantic Scholar
Biological indicators of prognosis in Ewing's sarcoma: An emerging role for lectin galactoside‐binding soluble 3 binding protein (LGALS3BP)
D. Zambelli, M. Zuntini, Filippo Nardi, M. Manara +10 more
2010International Journal of Cancer34 citations Open access
Semantic Scholar
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
B. Dufrusine, E. Capone, S. Ponziani, R. Lattanzio +8 more
2023Molecular Oncology33 citations Open access
Semantic Scholar
Prognostic relevance of LGALS3BP in human colorectal carcinoma
Enza Piccolo, N. Tinari, D. D’Addario, C. Rossi +8 more
2015Journal of Translational Medicine33 citations Open access
Semantic Scholar
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors.
N. Tinari, M. De Tursi, A. Grassadonia, M. Zilli +3 more
2012Current Cancer Drug Targets33 citations
Semantic Scholar
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
J. Vicencio, R. Evans, R. Green, Z. An +36 more
2022Cell Death and Disease31 citations Open access
Semantic Scholar
Inhibition of Tumor Growth and Angiogenesis by SP-2, an Anti–Lectin, Galactoside-Binding Soluble 3 Binding Protein (LGALS3BP) Antibody
S. Traini, Enza Piccolo, N. Tinari, C. Rossi +11 more
2014Molecular Cancer Therapeutics31 citations Open access
Semantic Scholar
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
E. Capone, F. Giansanti, S. Ponziani, A. Lamolinara +9 more
2017OncoTarget26 citations Open access
Semantic Scholar
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.
G. Sala, I. Rapposelli, R. Ghasemi, Enza Piccolo +9 more
2013Translational Oncology26 citations Open access
Semantic Scholar
Pharmacokinetics of Pegylated Liposomal Doxorubicin Administered by Intraoperative Hyperthermic Intraperitoneal Chemotherapy to Patients with Advanced Ovarian Cancer and Peritoneal Carcinomatosis
E. Salvatorelli, M. De Tursi, P. Menna, C. Carella +4 more
2012Drug Metabolism And Disposition24 citations
Semantic Scholar
Tumor-derived microvesicles: the metastasomes.
R. Ghasemi, A. Grassadonia, N. Tinari, Enza Piccolo +3 more
2013Medical Hypotheses23 citations
Semantic Scholar
An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis
G. Yahalom, D. Weiss, I. Novikov, T. Bevers +11 more
2013Biomarkers in Cancer23 citations Open access
Semantic Scholar
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
D. Angelucci, N. Tinari, A. Grassadonia, E. Cianchetti +12 more
2012Journal of Cancer Research and Clinical Oncology23 citations Open access
Semantic Scholar
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
E. Capone, Enza Piccolo, Imma Fichera, P. Ciufici +6 more
2017OncoTarget21 citations Open access
Semantic Scholar
Tyrosine kinase inhibitors.
C. Natoli, B. Perrucci, F. Perrotti, L. Falchi +1 more
2010Current Cancer Drug Targets21 citations
Semantic Scholar
Clinical Activity and Cardiac Tolerability of Non-Pegylated Liposomal Doxorubicin in Breast Cancer: A Synthetic Review
M. Airoldi, D. Amadori, S. Barni, S. Cinieri +14 more
2011Tumori20 citations
Semantic Scholar
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study
L. Cormio, B. Calò, U. Falagario, M. Iezzi +8 more
2020Journal of Translational Medicine18 citations Open access
Semantic Scholar
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
Aikaterini Emmanouilidi, C. Fyffe, R. Ferro, C. Edling +8 more
2019Journal of experimental & clinical cancer research : CR17 citations Open access
Semantic Scholar
Surface-enhanced Raman scattering (SERS)–based immunosystem for ultrasensitive detection of the 90K biomarker
Valentina Gallo, A. Lai, A. Pasquo, S. Almaviva +4 more
2020Analytical and Bioanalytical Chemistry16 citations Open access
Semantic Scholar
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
E. Capone, R. Lattanzio, F. Gasparri, P. Orsini +7 more
2021Pharmaceutics15 citations Open access
Semantic Scholar
Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
A. Grassadonia, M. Di Nicola, S. Grossi, P. Noccioli +13 more
2014Annals of Surgical Oncology15 citations Open access
Semantic Scholar
Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2
Valentina Gallo, Alyexandra Arienzo, S. Iacobelli, V. Iacobelli +1 more
2022International Journal of Molecular Sciences14 citations Open access
Semantic Scholar
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer.
D. D'Agostino, R. Gentile, S. Ponziani, Giulia Di Vittorio +10 more
2020Oncology Report14 citations Open access
Semantic Scholar
Unknown primary tumors.
C. Natoli, V. Ramazzotti, O. Nappi, P. Giacomini +7 more
2011Biochimica et Biophysica Acta13 citations
Semantic Scholar
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
C. Natoli, P. Vici, I. Sperduti, A. Grassadonia +16 more
2013Journal of Cancer Research and Clinical Oncology12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Sala×17
Invite
G. Sala — researcher profile on SciRah
E. Capone×15
Invite
E. Capone — researcher profile on SciRah
N. Tinari×15
Invite
N. Tinari — researcher profile on SciRah
C. Natoli×11
Invite
C. Natoli — researcher profile on SciRah

×10

Invite

C. Rossi — researcher profile on SciRah

Enza Piccolo×10

Invite

Enza Piccolo — researcher profile on SciRah

R. Lattanzio×10

Invite

R. Lattanzio — researcher profile on SciRah

V. De Laurenzi×10

Invite

V. De Laurenzi — researcher profile on SciRah

M. Piantelli×8

Invite

M. Piantelli — researcher profile on SciRah

Invite

M. De Tursi — researcher profile on SciRah

A. Grassadonia×7

Invite

A. Grassadonia — researcher profile on SciRah

Invite

P. Natali — researcher profile on SciRah